Evidence map›Paper›PMID 19393081›Full record

ArticleBMC biochemistry2009

Exploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release.

Jörg Votteler, Elena Iavnilovitch, Orit Fingrut, Vivian Shemesh, Daniel Taglicht, Omri Erez, Stefan Sörgel, Torsten Walther, Norbert Bannert, Ulrich Schubert and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BMC biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. How ubiquitin functions with ESCRTs.Traffic (Copenhagen, Denmark) · 2011
    Review
  11. Article
  12. Article
  13. New insights into HIV assembly and trafficking.Physiology (Bethesda, Md.) · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jörg VottelerInstitute of Virology, Friedrich-Alexander University, Erlangen, Germany. Joerg.Votteler@viro.med.uni-erlangen
Elena Iavnilovitch
Orit Fingrut
Vivian Shemesh
Daniel Taglicht
Omri Erez
Stefan Sörgel
Torsten Walther
Norbert Bannert
Ulrich Schubert
Yuval Reiss
Friedrich-Alexander-Universität Erlangen-Nürnberg · DERobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ALG2-interacting protein X (ALIX)/AIP1 is an adaptor protein with multiple functions in intracellular protein trafficking that plays a central role in the biogenesis of enveloped viruses. The ubiquitin E3-ligase POSH (plenty of SH3) augments HIV-1 egress by facilitating the transport of Gag to the cell membrane. Recently, it was reported, that POSH interacts with ALIX and thereby enhances ALIX mediated phenotypes in Drosophila.

resultsIn this study we identified ALIX as a POSH ubiquitination substrate in human cells: POSH induces the ubiquitination of ALIX that is modified on several lysine residues in vivo and in vitro. This ubiquitination does not destabilize ALIX, suggesting a regulatory function. As it is well established that ALIX rescues virus release of L-domain mutant HIV-1, HIV-1DeltaPTAP, we demonstrated that wild type POSH, but not an ubiquitination inactive RING finger mutant (POSHV14A), substantially enhances ALIX-mediated release of infectious virions derived from HIV-1DeltaPTAP L-domain mutant (YPXnL-dependent HIV-1). In further agreement with the idea of a cooperative function of POSH and ALIX, mutating the YPXnL-ALIX binding site in Gag completely abrogated augmentation of virus release by overexpression of POSH. However, the effect of the POSH-mediated ubiquitination appears to be auxiliary, but not necessary, as silencing of POSH by RNAi does not disturb ALIX-augmentation of virus release.

conclusionThus, the cumulative results identified ALIX as an ubiquitination substrate of POSH and indicate that POSH and ALIX cooperate to facilitate efficient virus release. However, while ALIX is obligatory for the release of YPXnL-dependent HIV-1, POSH, albeit rate-limiting, may be functionally interchangeable.

Indexed as

Binding SitesBlotting, WesternCalcium-Binding ProteinsCell Cycle ProteinsCell LineEndosomal Sorting Complexes Required for TransportHeLa CellsHIV-1HumansImmunoprecipitationMutationProtein BindingRecombinant ProteinsSubstrate SpecificityTransfectionUbiquitinationCalcium-Binding ProteinsCell Cycle ProteinsEndosomal Sorting Complexes Required for TransportPDCD6IP protein, humanRecombinant ProteinsSH3RF1 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID19393081
PMCPMC2680910
OpenAlexW1968305032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.